Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
11.95B | 10.59B | 11.96B | 11.93B | 11.86B | 12.02B | Gross Profit |
11.54B | 0.00 | 11.96B | 11.93B | 11.86B | 12.02B | EBIT |
2.07B | -578.00M | 1.47B | 1.14B | 771.00M | -1.69B | EBITDA |
626.00M | -578.00M | 866.00M | 1.76B | 607.00M | -1.07B | Net Income Common Stockholders |
-491.00M | -1.25B | 866.00M | 868.00M | 826.00M | -1.72B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
73.55B | 0.00 | 79.11B | 76.26B | 90.61B | 92.13B | Total Assets |
822.00B | 805.10B | 828.95B | 839.88B | 842.25B | 825.75B | Total Debt |
1.95B | 2.11B | 2.13B | 47.63B | 35.59B | 29.34B | Net Debt |
-71.60B | 2.11B | -76.98B | -28.62B | -55.01B | -62.79B | Total Liabilities |
797.19B | 781.03B | 803.87B | 815.60B | 814.89B | 796.11B | Stockholders Equity |
24.66B | 23.91B | 24.94B | 24.13B | 27.22B | 29.52B |
Cash Flow | Free Cash Flow | ||||
0.00 | 6.03B | 10.84B | -7.67B | 12.79B | 38.69B | Operating Cash Flow |
0.00 | 7.31B | 11.59B | -7.43B | 13.18B | 39.07B | Investing Cash Flow |
0.00 | -3.38B | 1.49B | -6.45B | -14.22B | -23.08B | Financing Cash Flow |
0.00 | -26.88B | -140.00M | -140.00M | -1.00M | -113.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥342.73B | 8.97 | 1.45% | 21.04% | 20.47% | ||
70 Outperform | $755.46B | 10.31 | 7.30% | 3.56% | 15.35% | -1.62% | |
65 Neutral | ¥112.78B | 8.33 | 2.99% | -0.27% | 38.79% | ||
64 Neutral | $12.77B | 9.71 | 7.85% | 78.05% | 12.07% | -7.97% | |
60 Neutral | ¥52.01B | 9.07 | 4.13% | 7.03% | 60.45% | ||
50 Neutral | ¥7.53B | ― | 2.31% | 1.71% | -164.25% |